Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
449
datasets available to search
ShareScore release 0.9.0
Dataset results
449 results for “depressive symptoms”
TreadWill, an Automated Intervention for Depressive Symptoms
ClinicalTrials.gov study NCT04703491. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression
ClinicalTrials.gov study NCT00146523. IPD Sharing: Not stated. Countries: 4. Publications: 4.
Brief Telephone Psychological Intervention for Depressive Symptoms in Caregivers
ClinicalTrials.gov study NCT02292394. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Meditation for Depression and Anxiety Symptoms in Dialysis Patients
ClinicalTrials.gov study NCT02686333. IPD Sharing: NO. Countries: 1. Publications: 1.
EMDR Psychotherapy to Treat Anxious-depressive Symptoms in Breast Cancer Patient
ClinicalTrials.gov study NCT03271476. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Online Positive Emotion Skills Intervention for Symptoms of Depression
ClinicalTrials.gov study NCT01964820. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Efficacy and Safety of Toluedesvenlafaxine Hydrochloride Extended-release Tablets in Somatic Symptoms of Depression
ClinicalTrials.gov study NCT05849272. IPD Sharing: NO. Countries: 1. Publications: 1.
An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression
ClinicalTrials.gov study NCT00128505. IPD Sharing: Not stated. Countries: 4. Publications: 3.
Cognitive-behavioral Intervention Via a Smartphone App for Depressive Symptoms in Caregivers
ClinicalTrials.gov study NCT03110991. IPD Sharing: NO. Countries: 1. Publications: 4.
The Effect of the Safe and Sound Protocol on Depression and Anxiety Symptoms
ClinicalTrials.gov study NCT06701578. IPD Sharing: NO. Countries: 1. Publications: 11.
Depressive Symptoms and Emotion Regulation Following Cognitive Behavioral Therapy
ClinicalTrials.gov study NCT03979963. IPD Sharing: Not stated. Countries: 1. Publications: 2.
The Use of Major Depression Inventory (MDI) in Measuring Preoperative Depressive Symptoms in Breast Cancer Patients
ClinicalTrials.gov study NCT01284751. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Data from: The effect of depressive symptoms on cognition in patients with fibromyalgia
Open the record for dataset details and reuse information.
Adverse childhood experiences, depressive symptoms, functional dependence, and physical activity: A moderated mediation model
<p>This release contains R scripts to analyze the links between adverse childhood experiences (ACEs), depression, functional dependence, and physical activity, using the SHARE panel data survey.</p>
Data for manuscript "The proportion of non-depressed subjects in a study sample strongly affects the results of psychometric analyses of depression symptoms"
<p>Data sets underlying the manuscript "The proportion of non-depressed subjects in a study sample strongly affects the results of psychometric analyses of depression symptoms" (doi: 10.1371/journal.pone.0235272). The file "data_table1.rds" contains the data underlying table 1 of the manuscript, whereas the file "data_figure1.rds" contains the data underlying figure 1. Both files are stored in RDS-format, which is a data format used in the programming language R. RDS-files can be loaded using R with the function readRDS(). Note that "data_figure1.rds" is a list of 22 elements. Elements 1, 21, and 22 are original data sets (depressed subjects, general population, and nondepressed subjects, respectively), while the remaining elements are lists each containing 500 newly generated data sets as described in the method section of the manuscript. For more details about the data please refer to the manuscript.</p>
Data from: Anxiety and depressive symptoms are associated with poor sleep health during a period of COVID-19 induced nation-wide lockdown: a cross-sectional analysis of adults in the Middle East
<p><strong>Background</strong>: Jordan, a Middle Eastern country, declared a state of national emergency due to the novel coronavirus (COVID-19) and a strict nation-wide lockdown on March 17, 2020, banning all travel and movement around the country, potentially impacting mental health. This study sought to investigate the association between mental health (e.g., anxiety and depressive symptoms) and sleep health among a sample of Jordanians living through a state of COVID-19 induced nation-wide lockdown.</p> <p><strong>Methods</strong>: Using Facebook, participants (N=1,240) in Jordan in March 2020 were recruited and direct to a web-based survey measuring anxiety (items from GAD-7 instrument), depressive symptoms (items from DES-10), sleep health (items from the PSQI), and sociodemographic. A modified Poisson regression model with robust error variance. Adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs) were estimated to examine how anxiety and depressive symptoms may affect different dimensions of sleep health: 1) poor sleep quality, 2) short sleep duration, 3) encountering sleep problems.</p> <p><strong>Results</strong>: The majority of participants reported having experienced mild (33.8%), moderate (12.9%), or severe (6.3%) levels of anxiety during lockdown, and nearly half of respondents reported depressive symptoms during lockdown. Similarly, over 60 percent of participants reported having experienced at least one sleep problem in the last week, and nearly half reported having had short sleep duration. Importantly, Anxiety was associated with poor sleep health outcomes. For example, corresponding to the dose-response relationship between anxiety and sleep health outcomes, those reporting severe anxiety were the most likely to experience poor sleep quality (aPR =8.95; 95% CI =6.12–13.08), short sleep duration (aPR =2.23; 95% CI = 1.91–2.61), and at least one problem sleep problem (aPR = 1.73; 95% CI = 1.54–1.95). Moreover, depressive symptoms were also associated with poor sleep health outcomes. As compared to scoring in the first quartile, scoring fourth quartile was associated with poor sleep quality (aPR = 11.82; 95% CI = 6.64 – 21.04), short sleep duration (aPR = 1.87; 95% CI = 1.58–2.22), and experiencing at least one sleep problem (aPR = 1.90; 95% CI = 1.66 – 2.18).</p> <p><strong>Conclusions</strong>: Increased levels of anxiety and depressive symptoms can negatively influence sleep health among a sample of Jordanian adults living in a state of COVID-19<br> induced nation-wide lockdown.</p>
Frequency of depressive symptoms in Syrian refugees and Turkish maintenance hemodialysis patients during COVID-19 pandemic
<p><strong>Introduction:</strong> Pneumonia of unknown cause was detected on 30 December 2019 in China. It was categorized as an outbreak and named as COVID-19 by the World Health Organization. The pandemic affects all people, but patient groups such as hemodialysis (HD) patients have been particularly affected. We do not know if refugees suffered more during the outbreak. In this study, we compared depressive symptom frequency between Syrian refugee HD patients and Turkish ones.</p> <p><strong>Methods:</strong> The study had a single-center, cross-sectional design. Demographic and clinical data were collected retrospectively from patients' files containing details about past medical history, demographic variables and laboratory values. Validated Turkish and Arabic forms of Beck Depression Inventory (BDI) were used to assess depressive symptoms. BDI scores were compared according to nationality, demographic features and clinical data. A BDI score more than 14 was accepted as suspicion of depression.</p> <p><strong>Results:</strong> 119 patients were enrolled in the study. After the exclusion of 22 patients, 75 Turkish and 22 Syrian patients were included for further analysis. The median BDI (interquartile range) score for Turkish and Syrian patients were 12 (7-23) and 19.5 (12.7-25.2), respectively (p=0.03). Suspicion of depression was present at 42.7% of Turkish, and 72.7% of Syrian HD patients (p=0.013). Regarding all patients, phosphorus level, Kt/V, and nationality were significantly different between patients with and without suspicion of depression (p=0.023, 0.039, 0.013, respectively).</p> <p><strong>Conclusion:</strong> Syrian patients had higher BDI scores and more depressive symptoms than Turkish patients. Additional national measures for better integration and more mental support to Syrian HD patients are needed. </p>
Data from: Patients with primary biliary cholangitis and fatigue present with depressive symptoms and selected cognitive deficits, but with normal attention performance and brain structure
Background: In primary biliary cholangitis (PBC) fatigue is a major clinical challenge of unknown etiology. By demonstrating that fatigue in PBC is associated with an impaired cognitive performance, previous studies have pointed out the possibility of brain abnormalities underlying fatigue in PBC. Whether structural brain changes are present in PBC patients with fatigue, however, is unclear. To evaluate the role of structural brain abnormalities in PBC patients severely affected from fatigue we, therefore, performed a case-control cerebral magnetic resonance imaging (cMRI) study and correlated changes of white and grey brain matter with the cognitive and attention performance. Methods: 20 female patients with PBC and 20 female age-matched controls were examined in this study. The assessment of fatigue, psychological symptoms, cognitive and attention performance included clinical questionnaires, established cognition tests and a computerized test battery of attention performance. T1-weighted cMRI and diffusion tensor imaging (DTI) scans were acquired with a 3 Tesla scanner. Structural brain alterations were investigated with voxel-based morphometry (VBM) and DTI analyses. Results were correlated to the cognitive and attention performance. Results: Compared to healthy controls, PBC patients had significantly higher levels of fatigue and associated psychological symptoms. Except for an impairment of verbal fluency, no cognitive or attention deficits were found in the PBC cohort. The VBM and DTI analyses revealed neither major structural brain abnormalities in the PBC cohort nor correlations with the cognitive and attention performance. Conclusions: Despite the high burden of fatigue and selected cognitive deficits, the attention performance of PBC patients appears to be comparable to healthy people. As structural brain alterations do not seem to be present in PBC patients with fatigue, fatigue in PBC must be regarded as purely functional. Future studies should evaluate, whether functional brain changes underlie fatigue in PBC.
Dataset of Association of depression and anxiety symptoms, and personal factors related to health behavior with tobacco abuse: A secondary data analysis.
Open the record for dataset details and reuse information.
STRICTA Check list for Effects of Electroacupuncture on Cognitive Symptoms in Major Depressive Disorder: A Pilot Study and Randomized Controlled Trial
<p>STRICTA 2010 check list</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.